Skip to main content
Caplight Logo









ZeitLife Transplant Innovations

ZeitLife Transplant Innovations

Private
New York City, New YorkHealthcare & Life Scienceshttps://zeitlife.com

Last Round

VC Round

Nov 16, 2023

Company Overview

ZeitLife Transplant Innovations is a medical device company that develops preservation fluids, machine perfusion systems, and organ transportation and logistics solutions for kidney transplantation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

organ preservationkidney transplantnormothermic machine perfusionNMPorgan perfusionorgan procurement organizationOPOtransplant logisticsmedical deviceperfusion fluidorgan transplant techcold chain logisticstransplant supply chainbiotech equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ZeitLife Transplant Innovations Comparables

Compare ZeitLife Transplant Innovations with similar companies based on industry and business-model similarity.

ZeitLife Transplant Innovations comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Global Transplant Solutions
88%
Getinge AB
81%
Carnamedica Sp. z o.o.
80%

ZeitLife Transplant Innovations Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 16, 2023

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 16, 2023

    Completed a VC Round funding round.

ZeitLife Transplant Innovations Filings

Explore SEC and related filing metadata, where available.

ZeitLife Transplant Innovations filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ZeitLife Transplant Innovations's valuation, stock price, and market status.

Is ZeitLife Transplant Innovations a public or private company?

ZeitLife Transplant Innovations is a private company.

What is the current stock price of ZeitLife Transplant Innovations?

ZeitLife Transplant Innovations is a private company with no public stock price. No recent secondary market data is available.

How much is ZeitLife Transplant Innovations worth (valuation)?

Valuation information for ZeitLife Transplant Innovations is not publicly available.

Can I buy ZeitLife Transplant Innovations stock?

ZeitLife Transplant Innovations shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ZeitLife Transplant Innovations's last funding round?

ZeitLife Transplant Innovations's most recent funding round was VC Round on November 16, 2023.

Who are the main investors in ZeitLife Transplant Innovations?

Investor information for ZeitLife Transplant Innovations is not publicly disclosed.

Will ZeitLife Transplant Innovations IPO soon?

No public IPO plans have been announced for ZeitLife Transplant Innovations.

How can I track ZeitLife Transplant Innovations secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ZeitLife Transplant Innovations's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Year Founded2022
Last FundingNov 16, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?